Product image of Norditropin Flexpro (Somatropin) supplied by GNH India

Norditropin Flexpro

Active Ingredient:
Somatropin
Origin:
EU

Norditropin Flexpro (Somatropin)

Somatropin, the active ingredient in Norditropin Flexpro, is a recombinant human growth hormone presented as a solution for injection for subcutaneous use. It is indicated for treating growth hormone deficiency and related growth disorders in children and adults.

GNH India supplies Norditropin Flexpro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable cold‑chain logistics for biologic products. Clients benefit from comprehensive regulatory support and timely delivery across multiple regions.

Manufacturer / TM Owner

Novo Nordisk A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Norditropin Flexpro, a recombinant human growth hormone, is used to address conditions characterized by insufficient endogenous growth hormone activity.

  • Growth hormone deficiency: promotes linear growth and improves metabolic parameters in children and adults with confirmed deficiency.
  • Turner syndrome: supports height increase and body composition improvements in girls with Turner syndrome.
  • Chronic renal insufficiency: enhances growth velocity in pediatric patients with renal failure.
  • Prader‑Willi syndrome: aids in improving body composition and growth outcomes.
  • Idiopathic short stature: facilitates height gain in children with unexplained short stature.

How It Works

  • Somatropin binds to specific growth hormone receptors on target cells, activating the JAK2‑STAT5 signaling cascade. This stimulates hepatic production of insulin‑like growth factor‑1 (IGF‑1) and other downstream mediators, leading to increased protein synthesis, cell proliferation, and linear bone growth. The combined endocrine and paracrine actions effectively restore normal physiological growth and overall metabolic functions in individuals lacking adequate endogenous hormone.

Side Effects

Somatropin therapy may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Injection site pain or erythema.
  • Headache.
  • Joint stiffness or arthralgia.
  • Peripheral edema.
  • Transient hyperglycemia.
  • Fatigue.

Serious or Rare Side Effects

  • Intracranial hypertension.
  • Slipped epiphysis (growth plate injury).
  • Pancreatitis.
  • Severe allergic reaction, including anaphylaxis.
  • Abnormal glucose metabolism progressing to diabetes.
  • Potential increased risk of tumor recurrence or new malignancy.

Precautions & Warnings

When prescribing Norditropin Flexpro, clinicians should observe several precautionary measures to ensure safe and effective use.

  • Dose titration: adjust based on IGF‑1 levels and growth response.
  • Monitoring: conduct regular assessments of glucose, thyroid, and cortisol status.
  • Contraindications: avoid use in patients with active malignancy.
  • Pregnancy and lactation: consider only if potential benefits outweigh risks.
  • Pediatric growth monitoring: watch for accelerated epiphyseal closure.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Somatropin can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid)

  • Glucocorticoids: may reduce somatropin effectiveness.
  • Estrogen therapy: can increase IGF‑1 levels and risk of adverse effects.
  • Insulin: may exacerbate hyperglycemia.
  • Diabetes medications: risk of unpredictable glucose control.

Moderate Interactions (Monitor Closely)

  • Oral contraceptives: may alter IGF‑1 dynamics.
  • Thyroid hormone replacement: requires monitoring of thyroid function.
  • CYP450 inducers (e.g., rifampin): potential impact on hormone metabolism.
  • Anti‑epileptic drugs: may affect growth hormone action.

Frequently Asked Questions

Norditropin Flexpro is a recombinant human growth hormone indicated for patients with growth hormone deficiency, Turner syndrome, chronic renal insufficiency, Prader‑Willi syndrome, and idiopathic short stature. It helps stimulate linear growth, improve body composition, and normalize metabolic functions in these conditions.

Somatropin binds to growth hormone receptors on target cells, triggering the JAK2‑STAT5 pathway. This leads to increased production of insulin‑like growth factor‑1 (IGF‑1) and other mediators that promote protein synthesis, cell proliferation, and bone growth, thereby restoring normal growth and metabolic activity.

The dose of Norditropin Flexpro is individualized. A qualified prescriber determines the appropriate amount based on the patient’s age, weight, IGF‑1 levels, and clinical response. Dosing regimens vary and should be followed exactly as prescribed.

Safety data for somatropin in pregnancy and lactation are limited. It should only be used when the potential benefits justify any potential risk to the fetus or infant. Physicians should discuss the risk‑benefit profile with the patient before initiating therapy.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details and necessary import documentation.

Norditropin Flexpro is a recombinant somatropin formulation delivered as a ready‑to‑use solution for subcutaneous injection. Compared with lyophilized powders that require reconstitution, Flexpro offers convenience and reduced preparation time. Clinical efficacy and safety are comparable to other approved growth‑hormone brands when used as directed.

The product must be stored refrigerated at 2‑8 °C, protected from light, and never frozen or shaken. Once in use, the solution can be kept at room temperature for a limited period as indicated in the product labeling, after which any remaining volume should be discarded.

Norditropin Flexpro is administered by subcutaneous injection, typically into the thigh, abdomen, or upper arm. The injection site should be rotated to minimize local reactions. Administration technique and timing are detailed in the prescribing information and should be performed by a trained healthcare professional or caregiver.

Serious risks include intracranial hypertension, slipped epiphysis, pancreatitis, severe allergic reactions, and abnormal glucose metabolism that may progress to diabetes. Patients should be monitored regularly for signs such as severe headache, visual changes, joint pain, abdominal pain, or unexplained hyperglycemia.

Norditropin Flexpro is contraindicated in individuals with active malignancy, known hypersensitivity to somatropin or any excipients, and in patients where growth hormone therapy is not indicated. Caution is also advised for those with uncontrolled diabetes, severe obesity, or a history of intracranial hypertension.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Somatropin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT